286 related articles for article (PubMed ID: 23341242)
1. The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating β-catenin-dependent transcription.
Renger A; Zafiriou MP; Noack C; Pavlova E; Becker A; Sharkova K; Bergmann MW; El-Armouche A; Zimmermann WH; Zelarayán LC
Stem Cells; 2013 May; 31(5):928-40. PubMed ID: 23341242
[TBL] [Abstract][Full Text] [Related]
2. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin and Bmp signals control distinct sets of transcription factors in cardiac progenitor cells.
Klaus A; Müller M; Schulz H; Saga Y; Martin JF; Birchmeier W
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10921-6. PubMed ID: 22711842
[TBL] [Abstract][Full Text] [Related]
4. Deletion of FHL2 in fibroblasts attenuates fibroblasts activation and kidney fibrosis via restraining TGF-β1-induced Wnt/β-catenin signaling.
Duan Y; Qiu Y; Huang X; Dai C; Yang J; He W
J Mol Med (Berl); 2020 Feb; 98(2):291-307. PubMed ID: 31927599
[TBL] [Abstract][Full Text] [Related]
5. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling.
Cai T; Sun D; Duan Y; Qiu Y; Dai C; Yang J; He W
J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729
[TBL] [Abstract][Full Text] [Related]
6. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
7. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
8. Proximal tubular FHL2, a novel downstream target of hypoxia inducible factor 1, is a protector against ischemic acute kidney injury.
Wang Y; Kuang Z; Xing X; Qiu Y; Zhang J; Shao D; Huang J; Dai C; He W
Cell Mol Life Sci; 2024 May; 81(1):244. PubMed ID: 38814462
[TBL] [Abstract][Full Text] [Related]
9. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b.
Brun J; Fromigué O; Dieudonné FX; Marty C; Chen J; Dahan J; Wei Y; Marie PJ
Bone; 2013 Mar; 53(1):6-12. PubMed ID: 23201222
[TBL] [Abstract][Full Text] [Related]
10. FHL2 participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via regulating the β-catenin pathway.
Zhou SG; Ma HJ; Guo ZY; Zhang W; Yang X
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2734-2741. PubMed ID: 29771425
[TBL] [Abstract][Full Text] [Related]
11. Temporal modulation of β-catenin signaling by multicellular aggregation kinetics impacts embryonic stem cell cardiomyogenesis.
Kinney MA; Sargent CY; McDevitt TC
Stem Cells Dev; 2013 Oct; 22(19):2665-77. PubMed ID: 23767804
[TBL] [Abstract][Full Text] [Related]
12. Wnt-promoted Isl1 expression through a novel TCF/LEF1 binding site and H3K9 acetylation in early stages of cardiomyocyte differentiation of P19CL6 cells.
Lu H; Li Y; Wang Y; Liu Y; Wang W; Jia Z; Chen P; Ma K; Zhou C
Mol Cell Biochem; 2014 Jun; 391(1-2):183-92. PubMed ID: 24610003
[TBL] [Abstract][Full Text] [Related]
13. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
[TBL] [Abstract][Full Text] [Related]
14. Identification of the LIM protein FHL2 as a coactivator of beta-catenin.
Wei Y; Renard CA; Labalette C; Wu Y; Lévy L; Neuveut C; Prieur X; Flajolet M; Prigent S; Buendia MA
J Biol Chem; 2003 Feb; 278(7):5188-94. PubMed ID: 12466281
[TBL] [Abstract][Full Text] [Related]
15. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
[TBL] [Abstract][Full Text] [Related]
16. The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts.
Martin B; Schneider R; Janetzky S; Waibler Z; Pandur P; Kühl M; Behrens J; von der Mark K; Starzinski-Powitz A; Wixler V
J Cell Biol; 2002 Oct; 159(1):113-22. PubMed ID: 12370240
[TBL] [Abstract][Full Text] [Related]
17. A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate.
Kwon C; Qian L; Cheng P; Nigam V; Arnold J; Srivastava D
Nat Cell Biol; 2009 Aug; 11(8):951-7. PubMed ID: 19620969
[TBL] [Abstract][Full Text] [Related]
18. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
Matulis CK; Mayo KE
Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-Catenin Stimulation and Laminins Support Cardiovascular Cell Progenitor Expansion from Human Fetal Cardiac Mesenchymal Stromal Cells.
Månsson-Broberg A; Rodin S; Bulatovic I; Ibarra C; Löfling M; Genead R; Wärdell E; Felldin U; Granath C; Alici E; Le Blanc K; Smith CIE; Salašová A; Westgren M; Sundström E; Uhlén P; Arenas E; Sylvén C; Tryggvason K; Corbascio M; Simonson OE; Österholm C; Grinnemo KH
Stem Cell Reports; 2016 Apr; 6(4):607-617. PubMed ID: 27052314
[TBL] [Abstract][Full Text] [Related]
20. Chibby, an antagonist of the Wnt/beta-catenin pathway, facilitates cardiomyocyte differentiation of murine embryonic stem cells.
Singh AM; Li FQ; Hamazaki T; Kasahara H; Takemaru K; Terada N
Circulation; 2007 Feb; 115(5):617-26. PubMed ID: 17261658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
